The Ministry of Rural Development (MRD) senior management has successfully concluded a two-day review of the first draft regulations for the Constituency Development Funds (CDF) Act 2023 last week ...

He highlighted significant progress in their "Win-in-MRD" strategy, driven by demand for the company’s ultra-sensitive MRD test, NeXT Personal. The company delivered over 2,000 molecular tests ...

Die Allianz hat im ersten Quartal einen Rekordgewinn erzielt. Dafür sorgten höhere Erträge aus dem Versicherungsgeschäft und Zuflüsse im Asset-Management. Wie der Versicherungsriese am ...

This launch is supported by a large genome-based molecular residual disease (MRD) study, which was accepted and will be presented at the 2025 American Society of Clinical Oncology (ASCO ...

Our study cohort comprised 463 patients with high-risk CM alterations and 72 patients with standard-risk (SR) CM results with positive MRD at end of induction I. In all, 33.9% and 45.8% of these ...

Personalis is a precision oncology company specializing in advanced genomics, with a strategic focus on minimal residual disease or MRD detection through its NeXT Personal platform. Q1 ...

The assay, previously available for research use only, is now ready for use in clinical settings, redefining the standard in MRD testing by enabling ultra-sensitive detection of circulating tumor ...

The best places to stay, eat, shop and visit across the country, according to Japanese artists, designers and chefs. Credit... Supported by By Danielle DemetriouMomoko IkedaKanae Hasegawa and Matt ...

What is the current share price of Mount Ridley Mines Limited (MRD)? Mount Ridley Mines Limited's (MRD) current share price is $0.00. This constitutes a price movement of 0% when compared to the share ...

As President Trump marks 100 days back in office, new polls show his approval rating around 40%, the lowest rating for the first 100 days of any presidency in 80 years. A Washington Post-ABC News ...